Key facts
- This page summarizes Scott Shuda's Form 4 filing for InfuSystem Holdings, Inc (INFU).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 May 2024, 19:23.
Scott Shuda - 14 May 2024 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)
- Reporting relationship
- Director
- Issuer ticker
- INFU
- Reported as of
- 14 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 May 2024, 19:23:04 UTC
- Prior SEC filing
- 15 Jun 2023
- Next SEC filing
- 21 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin R. Whitman, Attorney-in-Fact for Scott Shuda
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Scott Shuda filed Form 4 for InfuSystem Holdings, Inc (INFU) on 16 May 2024.
Change
- Previous filing in this sequence was filed on 15 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INFU
transaction
Common Stock
Options Exercise
- Transaction value
- $164,500
- Shares
- +35,000
- Change %
- +39%
- Price
- $4.70
- Shares after
- 125,494
- Date
- 14 May 2024
- Ownership
- Direct
INFU
transaction
Common Stock
Tax liability
- Transaction value
- $164,500
- Shares
- -23,500
- Change %
- -19%
- Price
- $7.00
- Shares after
- 101,994
- Date
- 14 May 2024
- Ownership
- Direct
- Footnotes
- F2
INFU
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 340,624
- Date
- 14 May 2024
- Ownership
- Footnote 1
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INFU
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -35,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 14 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,000
- Exercise price
- $4.70
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Mr. Shuda serves as Managing Director of (i) TSV Investment Partners, LLC, which is the sole general partner of Meridian OHC Partners, LP ("Meridian") and (ii) BlueLine Partners, LLC, which is the sole general partner of BlueLine Capital Partners II, LP ("BlueLine"). Accordingly, Mr. Shuda holds voting and dispositive power over the Common Stock held by Meridian and BlueLine. Mr. Shuda disclaims beneficial ownership for purposes of Rule 13d-3 with respect to the Common Stock held by Meridian and BlueLine.
Footnote F2
Reflects the number of shares surrendered in connection with the cashless exercise for the exercised option.
Footnote F3
The option, representing the right to purchase a total of 35,000 shares of InfuSystem Holdings, Inc. common stock, vested in twelve equal monthly installments beginning on June 15, 2019.